DE60336927D1 - - Google Patents

Info

Publication number
DE60336927D1
DE60336927D1 DE60336927T DE60336927T DE60336927D1 DE 60336927 D1 DE60336927 D1 DE 60336927D1 DE 60336927 T DE60336927 T DE 60336927T DE 60336927 T DE60336927 T DE 60336927T DE 60336927 D1 DE60336927 D1 DE 60336927D1
Authority
DE
Germany
Prior art keywords
provides
forms
cyprinus
carpino
vaccination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60336927T
Other languages
English (en)
Inventor
Moshe Kotler
Ayana Benet
Izhak Bejerano
Nissim Chen
Marina Hutoran
Ariel Ronen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MINISTRY OF AGRICULTURAL AND RURAL DEV Department OF FISHERIES AND AQUACULTURE
Yissum Research Development Co of Hebrew University of Jerusalem
Original Assignee
MINISTRY OF AGRICULTURAL AND RURAL DEV Department OF FISHERIES AND AQUACULTURE
Yissum Research Development Co of Hebrew University of Jerusalem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MINISTRY OF AGRICULTURAL AND RURAL DEV Department OF FISHERIES AND AQUACULTURE, Yissum Research Development Co of Hebrew University of Jerusalem filed Critical MINISTRY OF AGRICULTURAL AND RURAL DEV Department OF FISHERIES AND AQUACULTURE
Application granted granted Critical
Publication of DE60336927D1 publication Critical patent/DE60336927D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/00034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/00061—Methods of inactivation or attenuation
    • C12N2710/00064—Methods of inactivation or attenuation by serial passage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/03—Herpetoviridae, e.g. pseudorabies virus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Peptides Or Proteins (AREA)
  • Feed For Specific Animals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60336927T 2003-01-01 2003-12-22 Expired - Lifetime DE60336927D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL15377503A IL153775A0 (en) 2003-01-01 2003-01-01 Immunizing fish against viral infection
PCT/IL2003/001097 WO2004061093A1 (en) 2003-01-01 2003-12-22 Immunizing fish against viral infection

Publications (1)

Publication Number Publication Date
DE60336927D1 true DE60336927D1 (de) 2011-06-09

Family

ID=29798413

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60336927T Expired - Lifetime DE60336927D1 (de) 2003-01-01 2003-12-22

Country Status (12)

Country Link
US (1) US7351527B2 (de)
EP (1) EP1578959B1 (de)
JP (2) JP4690049B2 (de)
CN (1) CN100535108C (de)
AT (1) ATE507286T1 (de)
AU (1) AU2003288510A1 (de)
DE (1) DE60336927D1 (de)
DK (1) DK1578959T3 (de)
IL (2) IL153775A0 (de)
PL (1) PL209978B1 (de)
RU (1) RU2369635C2 (de)
WO (1) WO2004061093A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5109114B2 (ja) * 2006-02-24 2012-12-26 国立大学法人三重大学 魚類抗体産生の新規検出法
CN101495636B (zh) * 2006-04-13 2012-12-05 国立大学法人东京海洋大学 锦鲤疱疹病毒（khv）病用dna疫苗
JP5567244B2 (ja) * 2006-06-06 2014-08-06 共立製薬株式会社 魚類ストレプトコッカス・ディスガラクティエを抗原とする不活化ワクチン
WO2009027412A1 (en) 2007-08-28 2009-03-05 Universite De Liege A recombinant koi herpesvirus (khv) or cyprinid herpesvirus 3 (cyhv-3) and a vaccine for the prevention of a disease caused by khv/cyhv-3 in cyprinus carpio carpio or cyprinus carpio koi
EP2031065A1 (de) * 2007-08-28 2009-03-04 Université de Liège Rekombinanter Koi-Herpesvirus (KHV) oder Cyprinid-Herpesvirus 3 (CyHV-3) und Impfstoff zur Prävention einer von KHV/CyHV-3 bei Cyprinus carpio carpio oder Cyprinus carpio (Koi) verursachten Erkrankung
JP2010143860A (ja) * 2008-12-19 2010-07-01 Chisso Corp タンパク質の安定化剤
JP5462518B2 (ja) * 2009-04-09 2014-04-02 公益財団法人ヒューマンサイエンス振興財団 抗体精製方法
EP2487241A1 (de) 2011-02-09 2012-08-15 Westfälische Wilhelms-Universität Münster RNAi-Agenzien und -Zusammensetzungen, die als Therapeutika für Karpfen von Nutzen sind
RS61261B1 (sr) 2011-12-30 2021-01-29 Gesval S A Rekombinantni koi herpesvirus (khv) i vakcina za prevenciju bolesti prouzrokovane khv
EP2969966B1 (de) * 2013-03-15 2018-05-02 Atlantium Technologies Ltd. System und verfahren zur inaktivierung des infektiösen pankreasnekrose-virus mithilfe von optimiertem ultraviolett (uv)-licht
WO2014185439A1 (ja) * 2013-05-15 2014-11-20 独立行政法人水産総合研究センター コイ科ヘルペスウイルス－２（Ｃｙｐｒｉｎｉｄ ｈｅｒｐｅｓｖｉｒｕｓ－２：ＣｙＨＶ－２）感染症用ワクチンおよびその製造方法、ならびにＣｙＨＶ－２ウイルス製造方法
CN103430936A (zh) * 2013-09-06 2013-12-11 中国水产科学研究院黑龙江水产研究所 一种用于鱼类基因组dna提取的鱼鳍组织的制备方法
IL230970A0 (en) * 2014-02-13 2014-09-30 Univ Ramot Tilapia virus vaccines
CN104774802B (zh) * 2015-04-27 2017-12-08 上海海洋大学 银鲫鱼背鳍细胞系
RU2640346C1 (ru) * 2016-08-11 2017-12-27 Федеральное государственное бюджетное образовательное учреждение высшего образования "Государственный аграрный университет Северного Зауралья" (ФГБОУ ВО ГАУ Северного Зауралья) Способ антиоксидантной защиты мальков карпа

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780448A (en) * 1995-11-07 1998-07-14 Ottawa Civic Hospital Loeb Research DNA-based vaccination of fish

Also Published As

Publication number Publication date
JP2011024584A (ja) 2011-02-10
DK1578959T3 (da) 2011-08-15
IL153775A0 (en) 2003-07-31
JP4690049B2 (ja) 2011-06-01
CN100535108C (zh) 2009-09-02
JP2006512078A (ja) 2006-04-13
RU2369635C2 (ru) 2009-10-10
AU2003288510A8 (en) 2004-07-29
WO2004061093A1 (en) 2004-07-22
IL169412A (en) 2011-04-28
US20060013828A1 (en) 2006-01-19
CN1742083A (zh) 2006-03-01
US7351527B2 (en) 2008-04-01
ATE507286T1 (de) 2011-05-15
EP1578959A1 (de) 2005-09-28
EP1578959B1 (de) 2011-04-27
PL376441A1 (en) 2005-12-27
PL209978B1 (pl) 2011-11-30
AU2003288510A1 (en) 2004-07-29
RU2005120158A (ru) 2006-01-20

Similar Documents

Publication Publication Date Title
DE60336927D1 (de)
ATE426412T1 (de) Adjuvante influenza-vakzine
SG169375A1 (en) Yeast-based vaccine for inducing an immune response
MXPA05009580A (es) Vacuna contra el virus de la influenza.
WO2006068663A3 (en) Vaccine compositions for treating coronavirus infection
ATE451119T1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
WO2018140766A3 (en) Porcine coronavirus vaccines
EP1220925B8 (de) Chlamydia antigene und entsprechende dna-fragmente und ihre verwendungen
PT1409692E (pt) Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina
ATE310008T1 (de) Immunologische adjuvans verbindungen
DE60222296D1 (de) Impfstoff von umhüllten viren und verfahren zu seiner herstellung
UA86405C2 (ru) Способ вакцинации против инфекции семенников, вызванной вирусом бычьей вирусной диареи
TW200634156A (en) Neutralizing epitope-based growth enhancing vaccine
NO20020615D0 (no) Vaksine
ATE494377T1 (de) Vakzine gegen ipnv die aus hefezellen isoliert werden
BRPI0604365A (pt) polipeptìdeo isolado, composição de vacina anti-carrapato de múltiplas espécies, e, uso dos mesmos
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
MY148357A (en) Protein from photobacterium damselae and use thereof
HUP0402548A2 (hu) Madárembrió-részecskékből álló biomassza vírusantigének előállítására
UA33502A (uk) Спосіб виготовлення інактивованої вакцини проти сальмонельозів тварин
UA4626U (uk) Бівалентна інактивована концентрат-вакцина проти інфекційного ринотрахеїту та вірусної діареї великої рогатої худоби
CY1116907T1 (el) Ανασυνδυασμενα εμβολια κατα κωπηποδων καλιγιδων (θαλασσιων ψειρων) και αλληλουχιες αντιγονων αυτων
UA62746C2 (en) Emulsion vaccine associated inactivated against newcastle disease, infectious bronchitis of fowls, and syndrome of decreasing egg production-76
CY1114309T1 (el) Εμβολιο ροταϊου
MY146370A (en) Classical swine fever tissue culture live vaccine virus, the tissue culture method of the same and classical swine fever tissue culture live vaccine comprising the same